Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7BT5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,187
Award facts
- Contract value 100% obligated
- $39,186.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $39,186.89 on December 17, 2025, for the supply of Dupixent 300 mg/2 ml pen injections. This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 18, 2025, and performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to deliver a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and other government healthcare systems. The company's federal contract portfolio demonstrates substantial experience fulfilling competitive pharmaceutical procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices. This delivery order for Dupixent, a biologic treatment for atopic dermatitis and other inflammatory conditions, reflects the company's ongoing role as a prime vendor supporting the Defense Logistics Agency's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26F7BT5?
SPE2DR26F7BT5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26F7BT5 worth?
The government has obligated $39,187 on SPE2DR26F7BT5.
Is contract SPE2DR26F7BT5 an order under another contract?
Yes. SPE2DR26F7BT5 is a delivery order under SPE2DR25D3504, an indefinite delivery contract.
Was contract SPE2DR26F7BT5 competed?
The extent of competition for SPE2DR26F7BT5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award